As Some VCs Refill, Others Are Running Out Of Gas
This article was originally published in Start Up
Executive Summary
Life science VCs are posting strong across-the-board returns, allowing some firms to raise new funds larger than their prior vehicles. Still, the contraction that began nearly five years ago is still thwarting other firms’ efforts to press on through hard times.